Loading organizations...
Additio Investment Group is a venture capital firm specializing in Healthcare and Life Sciences investments. It targets innovative EU-based Seed and Series A opportunities, encompassing MedTech, Digital Health/HealthTech, and select Bio/Pharma. The firm provides industry expertise, network, and hands-on support, driving value creation for portfolio companies.
The firm launched in 2019 with its first fund, AiG1, established by an international syndicate of seasoned Healthcare and Life Sciences entrepreneurs, executives, and investors. This collective shared a passion for health/care innovation and a pragmatic approach to venture development. Their operating track record guides the firm’s investment strategy.
Additio Investment Group partners with companies demonstrating strong scaling potential and exceptional teams. It cultivates high-integrity entrepreneurial efforts within the health/care industry. The firm’s vision is to build impactful businesses advancing needs and progress across the healthcare and life sciences landscape.
Additio Investment Group has 1 tracked investment across 1 company. The latest tracked deal is $10.0M Series A in Oxford Endovascular in April 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2021 | Oxford Endovascular | $10.0M Series A | Parkwalk Advisors, Martin Diggle | Borealis Ventures, Oxford Science Enterprises, Norcliffe Capital, University OF Oxford, Oxford Investment Consultants, Perivoli Innovations |
